Rx/reimbursement adult incontinence saw a slight decline in volume and value terms in 2019 due to consumers moving away from the Rx/reimbursement channel because of insurance companies placing stricter policies on these products. Incontinence products for adults are partially covered by the German healthcare system, provided that a doctor’s prescription is issued. However, consumers are facing more constraints when it comes to the amount of money they can have reimbursed for adult incontinence p...

Euromonitor International’s Rx/Reimbursement adult incontinence in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2024 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years’ experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.